Congress_iStock-157582524_HomeFeature

Government Relations & Regulatory



We help companies navigate the rules and regulations that govern their industries. Knowing how government works, we navigate opportunities that open doors for growth, innovation and profit.

Our approach

Government regulations are complex. And every time the rules change, your company likely will face new challenges.

Nixon Peabody’s Government Relations & Regulatory practices offer the combined knowledge, experience and connections of more than 50 attorneys and professionals, many with backgrounds working for the agencies or legislative bodies governing our clients. Our team includes attorneys and advisors who have worked in various regulatory agencies, at both federal and state levels.

From our vantage point in Washington, DC, and in commercial centers across Europe and Asia, we help companies anticipate, navigate and comply with the myriad regulations that govern their industries.

Whether you need a voice in Congress or before a local administrative board, we advocate for legislative or policy changes that align with your business strategy.

Who we work with

Public and private organizations who want to stay ahead of the competition by anticipating government legislation, regulation and policy changes.

Regulatory and taste issues slow CBD formulation efforts

Food Business News | March 16, 2021

Government Investigations & White-Collar Defense deputy practice group leader and Boston partner Hannah Bornstein is quoted in this article on cannabidiol in food and beverage products for her outlook on therapeutic and marketing claims made by F&B manufacturers as areas of concern for the Food and Drug Administration.

Career Tracker: Law Firms Mark Start of 2021 with Wave of Lateral Hires

Reuters Legal | January 08, 2021

Notable legal moves highlight New York Government Investigations & White Collar Defense partner Travis Hill’s arrival to the firm.

Hire Up: Big Law's First 2021 Hires Focus on Government Compliance, Deal Practices

American Lawyer | January 08, 2021

Notable legal moves highlight New York Government Investigations & White Collar Defense partner Travis Hill’s arrival to the firm.

Ecco perché la democrazia Usa è a rischio. Parla l’avv. Bernardini

Formiche.net | November 14, 2020

This article features an interview with Nixon Peabody partner, Charles Bernardini, regarding President Trump’s challenge to the 2020 presidential election results.

Radio 24 con Charles Bernardini

Sole 24 Ore Radio 24 | November 06, 2020

This Italian radio segment features Nixon Peabody partner Charles Bernardini discussing procedural steps involved in challenging the 2020 USA presidential election results.

SEC: Actual Notice Is Needed to Bar Broker

Massachusetts Lawyers Weekly | September 24, 2020

This article covers the work of Boston Government Investigations & White-Collar Defense partner Rob Fisher and associate Scott Seitz in getting the Financial Industry Regulatory Authority (FINRA) to drop a lifetime ban for their client, after convincing the SEC that further proceedings were required. The story quotes both Rob and Scott.

Mass. Pot Co. Says Regulator Sat On Application for Months

Law360 | September 21, 2020

Manchester Government Investigations & White-Collar Defense partner Mark Knights is quoted in this article on a Massachusetts marijuana dispensary’s lawsuit alleging the state’s Cannabis Control Commission has failed to take action on the dispensary’s license application for nearly three times the 90-day prescribed turnaround time. The article mentions Mark and Boston Government Investigations & White-Collar Defense associate Charles Dell’Anno for representing the dispensary, Northeast Alternatives.

Increased Nursing Home Data Reporting Could Bring ‘Perfect Storm’ of Federal Lawsuits

Skilled Nursing News | September 21, 2020

This article, covering takeaways from a recent webinar on long-term care facility infection control enforcement, extensively quotes Washington DC Government Investigations & White-Collar Defense partner Adam Tarosky, who provided several best practices for skilled nursing facilities amid increased government scrutiny.

Congress lets leniency program for antitrust criminals lapse

CQ Roll Call | June 23, 2020

Washington, DC, Complex Commercial Disputes partner Gordon Lang, who leads the firm’s Antitrust, Regulatory and Unfair Trade Practices team, is quoted on the likelihood of Congress reauthorizing a leniency program for antitrust probes and why some large companies may at times be reluctant to come forward for fear of unnecessarily exposing themselves to civil liability risks.

Compliance Hot Spots

Law.com | June 09, 2020

This roundup of white-collar, regulatory and compliance news and trends mentions Affordable Housing and Real Estate partner Harry Kelly and Corporate partner Ken Silverberg, both of Washington, DC, for representing a businessman’s estate in a new tax case before the U.S. Court of Federal Claims in Washington.

Undefining ‘WOTUS’

Water Environment & Technology | November 26, 2019

This article features analysis by Rochester senior environmental health engineer Libby Ford on a proposed replacement rule that would restrict the federal government’s jurisdiction over waterways under the Clean Water Act.

21st Century Cures Act driving FDA changes

Modern Healthcare | September 07, 2019

This article discussing the 21st Century Cures Act’s ongoing impact on the Food and Drug Administration’s approval process quotes Boston Government Investigations and White Collar Defense partner Hannah Bornstein and Chicago Health Care partner Valerie Montague.

Devicemaker-doctor relationships ripe for fraud litigation

Modern Healthcare | August 23, 2019

This article quotes Washington, DC, Government Investigations and White Collar Defense partner Adam Tarosky for his perspective on the overlap between anti-kickback violations and False Claims Act violations when physicians are accused of accepted improper perks from medical device companies.

Boston Scientific asks judge to toss robocall suit

Law360 | July 12, 2019

This article highlights Boston Intellectual Property associate Troy Lieberman, who is representing Boston Scientific in a proposed class action suit alleging violations of the Telephone Consumer Protection Act.

GSK gets 2nd chance to argue preemption in Zofran MDL

Law360 | July 10, 2019

The following articles mention Boston Government Investigations and White Collar Defense partners Mark Seltzer and Brian French for their representation of GlaxoSmithKline in an ongoing matter related to the pharmaceutical company’s anti-nausea drug Zofran. One of the issues is whether federal law pre-empts state law in the case.

Judge to seek FDA’s views on Zofran birth defect cases against GSK

Reuters Legal | July 10, 2019

The following articles mention Boston Government Investigations and White Collar Defense partners Mark Seltzer and Brian French for their representation of GlaxoSmithKline in an ongoing matter related to the pharmaceutical company’s anti-nausea drug Zofran. One of the issues is whether federal law pre-empts state law in the case.

How should discharges to groundwater be regulated?

Rochester Business Journal | November 22, 2018

Rochester Corporate partner Jeremy Wolk wrote this contributed column on recent cases involving the Clean Water Act and discharges to groundwater, drawing from an alert by San Francisco partner Alison Torbitt, Albany associate Dana Stanton and senior environmental health engineer Libby Ford, all of the Affordable Housing & Real Estate group.

Back to top